In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.
, who directs the Yale Alzheimer's Disease Research Center and presented an overview of the study at the meeting.of the National Institute on Aging, who was not involved in the study, called the results"a very small effect."
Thambisetty emphasized that his views are his own, and that he is not speaking for the NIA, which is part of the National Institutes of Health.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New Drug Shows Signs of Slowing Cognitive Decline in Alzheimer's Patients, Study FindsAn experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening, researchers reported -- but it remains unclear how much difference that might make in people’s lives.
Read more »
Study shows Pfizer vaccine effectiveness decreases with ageThe effectiveness of the Pfizer COVID-19 vaccine diminishes as patients get older, according to a new study by UT Southwestern Medical Center researchers....
Read more »
Study: Alzheimer's drug lecanemab shows moderate benefit for people with mild diseaseA new study released Tuesday showed a closely-watched Alzheimer's drug slowed cognitive decline among people with early signs of the disease also carries safety risks for some patients.
Read more »
Alternative investments have not helped public pension plan returns, study showsIn recent years, they have actually hurt; although they may have dampened volatility.
Read more »
Improve memory as you age by eating more flavonols, study says | CNNEating more flavonols, antioxidants found in many vegetables, fruits, tea and wine, may slow your rate of memory loss, a new study finds.
Read more »
Number of handgun owners carrying firearm each day doubles: StudyThe number of handgun owners carrying a firearm each day has doubled in recent years.
Read more »